{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:24:40Z","timestamp":1784247880032,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.thromres.2024.109205","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T18:29:56Z","timestamp":1731176996000},"page":"109205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Understanding European patterns of deprescribing antithrombotic medication during end-of-life care in patients with cancer"],"prefix":"10.1016","volume":"245","author":[{"given":"E.S.L.","family":"Martens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Abele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Abbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.P.","family":"Achterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bertoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Font","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Goedegebuur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"H\u00f8jen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.V.","family":"Huisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.H.A.","family":"Kruip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Mah\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.P.","family":"Mooijaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Seddon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Szmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.I.R.","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.A.","family":"Klok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.V.","family":"Konstantinides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.thromres.2024.109205_bb0005","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1093\/eurheartj\/ehab171","article-title":"Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis","volume":"42","author":"Grilz","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2024.109205_bb0010","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221081121","article-title":"Venous thromboembolism in patients with cancer receiving specialist palliative care","volume":"28","author":"Allende-P\u00e9rez","year":"2022","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"8","key":"10.1016\/j.thromres.2024.109205_bb0015","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/pds.5223","article-title":"Use of preventive drugs during the last year of life in older adults with cancer or chronic progressive diseases","volume":"30","author":"Bosetti","year":"2021","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"5","key":"10.1016\/j.thromres.2024.109205_bb0020","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/ejh.13834","article-title":"Thromboprophylaxis for inpatient with advanced cancer receiving palliative care: a retrospective study","volume":"109","author":"Al-Ansari","year":"2022","journal-title":"Eur. J. Haematol."},{"issue":"1","key":"10.1016\/j.thromres.2024.109205_bb0025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12904-021-00786-3","article-title":"Use of antithrombotics at the end of life: an in-depth chart review study","volume":"20","author":"Huisman","year":"2021","journal-title":"BMC Palliat. Care"},{"key":"10.1016\/j.thromres.2024.109205_bb0030","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijcard.2017.03.132","article-title":"Atrial fibrillation in cancer patients: hindsight, insight and foresight","volume":"240","author":"Mery","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.thromres.2024.109205_bb0035","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/bloodadvances.2021005590","article-title":"The incidence of cancer-associated thrombosis is increasing over time","volume":"6","author":"Mahajan","year":"2022","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.thromres.2024.109205_bb0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11739-014-1064-9","article-title":"Cardiovascular oncology: a new discipline inside internal medicine?","volume":"9","author":"Prisco","year":"2014","journal-title":"Intern. Emerg. Med."},{"issue":"3","key":"10.1016\/j.thromres.2024.109205_bb0045","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/jth.13606","article-title":"Bleeding risk of terminally ill patients hospitalized in palliative care units: the RHESO study","volume":"15","author":"Tardy","year":"2017","journal-title":"J. Thromb. Haemost."},{"issue":"e6","key":"10.1016\/j.thromres.2024.109205_bb0050","doi-asserted-by":"crossref","first-page":"e834","DOI":"10.1136\/bmjspcare-2019-001804","article-title":"Management of venous thromboembolism in far-advanced cancer: current practice","volume":"12","author":"Noble","year":"2022","journal-title":"BMJ Support. Palliat. Care"},{"issue":"13","key":"10.1016\/j.thromres.2024.109205_bb0055","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/cncr.32044","article-title":"Preventive drugs in the last year of life of older adults with cancer: is there room for deprescribing?","volume":"125","author":"Morin","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.thromres.2024.109205_bb0060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.thromres.2018.05.025","article-title":"Prevalence and correlates of bleeding and emotional harms in a national US sample of patients with venous thromboembolism: a cross-sectional structural equation model","volume":"172","author":"Feehan","year":"2018","journal-title":"Thromb. Res."},{"issue":"12","key":"10.1016\/j.thromres.2024.109205_bb0065","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006544","article-title":"Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis","volume":"4","author":"Anderson","year":"2014","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.thromres.2024.109205_bb0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41514-023-00132-2","article-title":"Attitudes and barriers towards deprescribing in older patients experiencing polypharmacy: a narrative review","volume":"10","author":"Robinson","year":"2024","journal-title":"NPJ Aging"},{"issue":"2","key":"10.1016\/j.thromres.2024.109205_bb0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/eurjcn\/zvaa020","article-title":"Flash mob studies: a novel method to accelerate the research process","volume":"20","author":"Moons","year":"2021","journal-title":"Eur. J. Cardiovasc. Nurs."},{"key":"10.1016\/j.thromres.2024.109205_bb0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2023.05.008","article-title":"Towards optimal use of antithrombotic therapy of people with cancer at the end of life: a research protocol for the development and implementation of the SERENITY shared decision support tool","volume":"228","author":"Goedegebuur","year":"2023","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2024.109205_bb0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1472-6947-12-75","article-title":"Diagnosis and management of people with venous thromboembolism and advanced cancer: how do doctors decide? A qualitative study","volume":"12","author":"Johnson","year":"2012","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"10.1016\/j.thromres.2024.109205_bb0090","series-title":"IBM SPSS Statistics for Windows, Version 29.0.0.0","author":"IBM Corp","year":"2023"},{"issue":"11","key":"10.1016\/j.thromres.2024.109205_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v095.i11","article-title":"Estimation of random utility models in R: the mlogit package","volume":"95","author":"Croissant","year":"2020","journal-title":"J. Stat. Softw."},{"issue":"6","key":"10.1016\/j.thromres.2024.109205_bb0100","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the eastern cooperative oncology group","volume":"5","author":"Oken","year":"1982","journal-title":"Am. J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.thromres.2024.109205_bb0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S2213-2600(19)30354-6","article-title":"Trends in mortality related to pulmonary embolism in the European Region, 2000\u201315: analysis of vital registration data from the WHO Mortality Database","volume":"8","author":"Barco","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"8","key":"10.1016\/j.thromres.2024.109205_bb0110","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1089\/jpm.2017.0501","article-title":"Medication discontinuation at the end of life: a questionnaire study on physicians\u2019 experiences and opinions","volume":"21","author":"Geijteman","year":"2018","journal-title":"J. Palliat. Med."},{"issue":"1","key":"10.1016\/j.thromres.2024.109205_bb0115","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/10499091211003078","article-title":"Deprescribing in older adults with cancer and limited life expectancy: an integrative review","volume":"39","author":"Brokaar","year":"2022","journal-title":"Am. J. Hosp. Palliat. Care"},{"issue":"4","key":"10.1016\/j.thromres.2024.109205_bb0120","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00520-013-2098-7","article-title":"Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches","volume":"22","author":"Lindsay","year":"2014","journal-title":"Support Care Cancer"},{"issue":"11","key":"10.1016\/j.thromres.2024.109205_bb0125","doi-asserted-by":"crossref","first-page":"11301","DOI":"10.21037\/apm-21-1788","article-title":"Potentially inappropriate medication discontinued or changed based on pharmacists\u2019 recommendations in older end-stage cancer patients receiving palliative care: a cross-sectional study","volume":"10","author":"Takahashi","year":"2021","journal-title":"Ann. Palliat. Med."},{"issue":"3","key":"10.1016\/j.thromres.2024.109205_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgo.2023.101472","article-title":"Potentially inappropriate medication use based on two deprescribing criteria and related factors in patients with terminal cancer: a cross-sectional study","volume":"14","author":"Kim","year":"2023","journal-title":"J. Geriatr. Oncol."},{"issue":"1","key":"10.1016\/j.thromres.2024.109205_bb0135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/ejhpharm-2021-003143","article-title":"The potential for deprescribing in a palliative oncology patient population: a cross-sectional study","volume":"31","author":"van Merendonk","year":"2023","journal-title":"Eur. J. Hosp. Pharm."},{"key":"10.1016\/j.thromres.2024.109205_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/spcare-2024-004849","article-title":"Deprescribing in older patients with advanced cancer referred to palliative care","author":"Fern\u00e1ndez-Fradejas","year":"2024","journal-title":"BMJ Support. Palliat. Care"},{"issue":"1","key":"10.1016\/j.thromres.2024.109205_bb0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00520-014-2322-0","article-title":"The development and evaluation of an oncological palliative care deprescribing guideline: the \u2018OncPal deprescribing guideline\u2019","volume":"23","author":"Lindsay","year":"2015","journal-title":"Support Care Cancer"},{"issue":"6","key":"10.1016\/j.thromres.2024.109205_bb0150","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1055\/s-0041-1725115","article-title":"Physicians\u2019 opinions on anticoagulant therapy in patients with a limited life expectancy","volume":"47","author":"Huisman","year":"2021","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2024.109205_bb0155","series-title":"Nursing Care at the End of Life: What Every Clinician Should Know","author":"Lowey","year":"2015"},{"issue":"4","key":"10.1016\/j.thromres.2024.109205_bb0160","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4103\/ijccm.IJCCM_165_18","article-title":"Definition of terms used in limitation of treatment and providing palliative care at the end of life: the Indian council of medical research commission report","volume":"22","author":"Salins","year":"2018","journal-title":"Indian J. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.thromres.2024.109205_bb0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpainsymman.2013.02.021","article-title":"Concepts and definitions for \u201cactively dying,\u201d \u201cend of life,\u201d \u201cterminally ill,\u201d \u201cterminal care,\u201d and \u201ctransition of care\u201d: a systematic review","volume":"47","author":"Hui","year":"2014","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.thromres.2024.109205_bb0170","series-title":"End of life care for adults: service delivery","author":"National Institute for Health and Care Excellence: Guidelines","year":"2019"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824003372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824003372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T18:33:02Z","timestamp":1735237982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824003372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":34,"alternative-id":["S0049384824003372"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109205","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding European patterns of deprescribing antithrombotic medication during end-of-life care in patients with cancer","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109205"}}